ESA Biosciences and Waters Corporation Announce Collaboration
News Mar 27, 2008
ESA Biosciences and Waters Corporation have announced that the two companies are working together to integrate the ESA Corona® CAD® universal HPLC detector with the Waters chromatography control and data-analysis platform: Empower® 2.
The Corona charged-aerosol detector (CAD) can analyze a wide diversity of chemical structures and important classes of molecules - from small organic molecules, proteins and peptides, to ions, carbohydrates, lipids, and polymers.
Many scientists in the pharmaceutical industry already combine a Waters Empower 2 software-controlled LC System with the Corona CAD detector for applications ranging from excipient and formulation characterization and forced-degradation studies to impurity analysis, cleaning validations, and final product QC.
"In working with ESA Biosciences, we are responding to the needs of our Empower 2 software users who are using the Corona CAD for their applications. By adding a new feature into our Empower software to control ESA's detector, we're giving our customers more choices and more ways to be successful," said Bill Foley, Director - Product Marketing, Waters Corporation.
ESA's Vice President of Life Sciences Marketing, Jasmine Gruia-Gray, said, "We listen closely to customer suggestions for product enhancements - a key part our commitment to continuously improve results and help scientists do their jobs better, faster, and easier. Customers have asked for a direct interface between the Corona CAD and Empower platforms. We're pleased to work with Waters so we can meet our respective customers' needs."
"Non-Gene" Mutations May Hold Answers to Neurodevelopmental DisordersNews
Mutations in non-coding regions of the genome, which don't contain genes, but control the regulation of other genes, may hold answers to rare developmental disorders that affect the nervous system.READ MORE
Majority of European Wolves Have Dog DNANews
The wolf may not often act like man's best friend, but a new study has found that the majority of wild wolves in Europe contain chunks of dog DNA. The finding is causing scientists to rethink what constitutes a wolfdog hybrid and how we approach conservation of keystone wolf populations.READ MORE
Neuroblastoma Biomarker Research Advances TreatmentNews
Neuroblastoma, a childhood cancer, is treatable in less than half of aggressive cases, but new RNA biomarkers may help identify high-risk patients faster and lead to better prognosis.READ MORE